Fundz

Scipher Medicine Acquires Crossbridge And Its Saas Platform To Collect And Map Patient Molecular, Outcomes And Claims Data In Real Time

RECENTLY ACQUIREDJan 10, 2023

Acquiring Company

Scipher Medicine

Acquired Company

scnd

WalthamParisBiotechnologyHealth CareMedicalTherapeutics

Description

Scipher Medicine, a precision immunology company matching each patient with their most effective therapy, has acquired Philadelphia-based data, analytics, and software company CrossBridge to bolster its data and analytics capabilities.

Who to call at Scipher Medicine, and when

When Scipher Medicine changes hands, the new owners review vendors, systems and leadership. That is when the door opens.

  • An alert the day Scipher Medicine raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Scipher Medicine, from your own LinkedIn network
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Scipher Medicine

Location

500 TOTTEN POND ROAD, 6TH FLOOR

Waltham, Massachusetts, United States

About

Scipher Medicine, a precision immunology company matching patients with their most effective therapy, believes that patients deserve simple answers to treatment options based on scientific data. Using Spectra™, our proprietary network medicine platform, we commercialize tests revealing a person’s unique molecular disease signature and match it to the most effective therapy, ensuring optimal treatment from day one. The patient molecular data generated from our tests further supports the discovery and development of novel and more effective therapeutics. We partner with leading payers, health care providers, and pharmaceutical companies to bring solutions to patients with autoimmune diseases. Visit http://www.sciphermedicine.com and follow Scipher Medicine on Twitter, Facebook, and LinkedIn.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Scipher Medicine makes an acquisition, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

Jessica
Senior decision-maker at this company
••••••••@••••••••

See Jessica's verified email →

Reginald
Senior decision-maker at this company
••••••••@••••••••

See Reginald's verified email →

Create an account to reveal verified emails
Predictive Intelligence
Strategic

ML-powered predictions for Scipher Medicine's next move

Learn about Strategic plan

Frequently asked

Who acquired scnd?

scnd was acquired by Scipher Medicine, based in Waltham. The deal was reported on January 10, 2023. Scipher Medicine, a precision immunology company matching patients with their most effective therapy, believes that patients deserve simple answers to treatment options based on scientific data. Scipher Medicine is privately held and operates in Biotechnology.

When did Scipher Medicine acquire scnd?

Scipher Medicine's acquisition of scnd was reported on January 10, 2023. Scipher Medicine, a precision immunology company matching each patient with their most effective therapy, has acquired Philadelphia-based data, analytics, and software company CrossBridge to bolster its data and analytics capabilities. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.

What does scnd do?

scnd reinvents the way people buy and sell services online by developing a marketplace software. It is privately held, and is based in Paris.

This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include FundzWatch™ for automated website change detection, Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.